google-site-verification=OIFzd9VZmCKIIkdj8kgelmd1b_GxU-xz2VhUumtQFCM, pub-2516799717020337, DIRECT, f08c47fec0942fa0
  • HueFin News

Oppenheimer Maintains Buy Ratings For CBAY Price Target $19

Oppenheimer Maintains a Buy Rating on CymaBay Therapeutics (CBAY)

Oppenheimer has a price target for CBAY at $19. Not so fast. The price chart is displaying it will not make it that high. The price chart is showing a price target of $10 - $12, maybe $14.

1 view0 comments